meta
|
evidence
COVID-19
Living systematic review and meta-analysis
Spikevax (Moderna mRNA-1273 COVID-19 vaccine)
adjuvant therapies
anti-inflammatoty and immuno-therapy
antiandrogenic
antiviral and associated therapy
control
Drugs for acid related disorders
miscellaneous
Oral antidiabetic drugs
Renin-angiotensin-system-acting agents
vaccines
mRNA vaccine
Comirnaty (tozinameran - Pfizer/BIONTECH)
CureVac
Spikevax (Moderna mRNA-1273 COVID-19 vaccine)
Vitamins
Filter by comparators...
potential COVID-19 treatments
control
placebo
uncontrolled study
COVID 19 hospitalized
All
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 (hospitalized or not)
COVID-19 prophylaxis (children)
COVID-19 prophylaxis (excluding children)
infections other than COVID-19
Long COVID-19
preventing respiratory virus transmission
secondary prevention
patient subgroup...
patient subgroup...
adolescents (typically 12-15 years of age)
age >= 65 yr
alpha variant (B.1.1.7, UK)
children
delta variant (B.1.617.2, Indian)
elderly (typically over 65yr)
kidney transplant recipients
omicron variant BA.1 (B.1.1.529)
solid organ transplant recipients
subjects at risk
patient subgroup...
adolescents (typically 12-15 years of age)
age >= 65 yr
alpha variant (B.1.1.7, UK)
children
delta variant (B.1.617.2, Indian)
elderly (typically over 65yr)
kidney transplant recipients
omicron variant BA.1 (B.1.1.529)
solid organ transplant recipients
subjects at risk
Studies
Mapping
Meta-analysis
Excluded
Study
Exclusion reasons
Remarks
Reference(s)
Empty list - no studies excluded